Basics FibroGen, Inc FibroGen Inc is a biopharmaceutical company. It is engaged in the discovery, development and commercialization of novel therapeutics to treat serious unmet medical needs. IPO Date: November 14, 2014 Sector: Healthcare Industry: Biotech Market Cap: $34.06M Activated in VL: True Average Daily Range Avg Daily Range: $0.62 | 3.04% Avg Daily Range (30 D): $0.19 | 1.95% Avg Daily Range (90 D): $0.30 | 2.89% Institutional Daily Volume Avg Daily Volume: .86M Avg Daily Volume (30 D): .03M Avg Daily Volume (90 D): .03M Trade Size Avg Trade Size (Sh.): 137 Avg Trade Size (Sh.) (30 D): 129 Avg Trade Size (Sh.) (90 D): 109 Institutional Trades Total Inst.Trades: 4,004 Avg Inst. Trade: $2.19M Avg Inst. Trade (30 D): $.67M Avg Inst. Trade (90 D): $.67M Avg Inst. Trade Volume: M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $2.9M Avg Closing Trade (30 D): $9.03M Avg Closing Trade (90 D): $9.03M Avg Closing Volume: 4.91K     News Aug 18, 2025 @ 11:00 AM FibroGen Announces Approval of Sale of FibroGen Ch... Source: Fibrogen, Inc. Feb 20, 2025 @ 6:08 PM Amid Mounting Pressure In China, AstraZeneca Buys ... Source: Vandana Singh Sep 2, 2024 @ 8:15 PM Liver Fibrosis Market Is Expected to Reach USD 43.... Source: The Brainy Insights Aug 23, 2024 @ 10:04 PM Catalyst Accelerator Ogden Selects 11 Companies fo... Source: Catalyst Accelerator Ogden Jun 3, 2024 @ 8:48 PM FibroGen Stock Is Surging After The Bell: What's G... Source: Adam Eckert Financials   TTM Q3 2025 Q2 2025 Basic EPS $64.85 $49.61 $-1.88 Diluted EPS $64.85 $49.61 $-1.88 Revenue $ 8.3M $ 1.08M $ 1.35M Gross Profit $ 13.87M $ 1.13M $ 1.26M Net Income / Loss $ 215.65M $ 200.64M $ -7.6M Operating Income / Loss $ -39.52M $ -5.41M $ -12.05M Cost of Revenue $ -5.57M $ -.06M $ .09M Net Cash Flow $ 48.68M $ -.6M $ 12.66M PE Ratio 0.13     Splits Jun 17, 2025:   1:25